Your digital and compliance partner in Life Sciences

Life Sciences is one of the world’s most vital industries—at its core lies what matters most: our health and well-being. At Sopra Steria, we recognise the responsibility Life Sciences companies carry: delivering breakthrough therapies and technologies while meeting the highest regulatory and quality standards.

That is where we come in. Our strength lies in combining deep regulatory knowledge with tailored digital solutions. From lab equipment qualification to manufacturing system validation, our integrated services ensure robust compliance, operational excellence and readiness for tomorrow. We enable Life Sciences organisations to innovate faster—without compromising on quality or control.

Digital transformation is no longer a future ambition—it is today’s imperative

As Industry 4.0 reshapes manufacturing and operations, Life Sciences is being redefined by smart technologies: IoT, robotics, AI and advanced data analytics. At Sopra Steria, we are helping organisations embrace this shift— with confidence and full compliance. Whether it's GxP system validation, IT infrastructure qualification, or full-spectrum QA support, our experts guide you every step of the way.

We are more than consultants—we are problem-solvers and enablers. From QMS implementation to remediation projects, our compliance teams bring insight and rigour. And when it comes to innovation, we are leading the way: using AI to build future-fit systems and deploying low-code platforms like Mendix for rapid, user-driven development—reducing time-to-market by up to 80%.

With Sopra Steria, your digital journey in Life Sciences becomes faster, smarter and always compliant.

Comprehensive Qualification and Validation Services

We deliver qualification and validation services for IT infrastructure, lab equipment, and computerized systems—ensuring your operations are compliant, reliable, and audit-ready throughout their lifecycle. 

QMS Management, QA Support & Audit Services

We implement and manage your QMS, and also provide QA operations support—such as managing deviations, risk assessments, root cause analyses, and CAPAs. We conduct audits and assessments to evaluate your compliance and help close any gaps—ensuring audit readiness and building trust.

Tailored Digital Innovation & Transformation

We guide your digital journey with AI, low-code platforms, and data-driven tools—accelerating innovation while ensuring regulatory compliance, system security, and future-ready operations. 

Partner with Sopra Steria and stay ahead in a world of constant change

We bring together regulatory rigour, digital expertise, and an unwavering commitment to patient safety—to help you accelerate innovation and improve lives.

Explore our Life Sciences Service Catalogue and discover what is possible.

Our Services

IT Infrastructure Qualification
Computerized System Validation / Software Quality Assurance
Lab Instrument and Operation Services
Manufacturing Support
Quality and Compliance Support
Assessment and Audit Services
Business Analysis and Project Management
Accelerate and Innovate with AI & Mendix

Whitepaper

Digital acceleration for faster, more accessible therapies
Revolutionize drug development: cut costs and time while enhancing patient safety with digital acceleration.
Read more

Digital Themes

Our success stories

Revolutionising clinical manufacturing with low-code

Sep 18, 2024, 06:47 AM
Title : Revolutionising clinical manufacturing with low-code
Button label :

In the high-stakes world of pharmaceuticals and life sciences, the race to bring groundbreaking medication to market has never been more intense. In this industry case, you will learn about the captivating journey with a pharma industry giant, where cutting-edge technology meets innovation to transform manufacturing. Prepare to be inspired by the future of medication development.

The challenges: the race for rapid innovation

Luckily, the global pandemic is not top of mind anymore, but during that period, the race to develop a COVID-19 vaccine underscored the need for rapid innovation. The primary challenges faced included the necessity for a secure, scalable, flexible, and cost-effective manufacturing platform. Time-to-market became a crucial differentiator, and adopting new technologies was imperative to stay ahead in the competitive life sciences landscape.

The solution: Mendix and low-code technology

Our approach focused on utilising Mendix, a trusted low-code platform, to tackle these challenges. Tailoring Mendix components towards specific use cases, we created a Low-code Accelerator Suite which was employed to fuel a Manufacturing Execution System (MES).  

This suite is known for its:

  • Cost-effectiveness: 2-4 times cheaper than competitors like Tulip and PasX.
  • Speedy implementation: 2-3 months compared to multiple years required by competitors.
  • Flexibility: easily adaptable to users' needs due to its low-code technology.
  • Client Control: empowers users with full control over their processes.

By combining pre-built components with newly created functionality tailored to specific use cases, we ensured a perfect fit for the pharma giant's requirements. Built on the globally recognized S88 standard, the solution emphasised delivering a cost-effective, agile, and flexible platform.

Implementation and outcomes

The implementation phase focused on creating a Master Batch Record (MBR) visual design functionality within the S88 standard. S88 is a set of guidelines for batch process control in manufacturing, which helps organise and manage production processes more efficiently.

This allowed for flexible creation, auditability, approval workflows, and seamless execution of Electronic Batch Records (EBRs). Integration into existing systems ensured adaptability to future needs.

Overcoming potential hurdles, our team worked closely with our client to configure and optimise the MBR creation process. Real-time adaptability was a priority, allowing for swift adjustments and enhancements as required. Transparent communication fostered a successful implementation, resulting in a fully integrated, auditable, and efficient MBR execution process.

Transformative results

The most significant achievement was reducing the development time, significantly: from months to a few weeks. This remarkable reduction positioned the pharma giant as an industry leader in responsiveness, bringing about substantial cost savings. Our solution streamlined the MBR creation process, enhancing efficiency and auditability. The end-to-end integration ensured a seamless workflow, from creation to approval and execution.

In a landscape where innovation is paramount, our MES implementation exemplifies our commitment to revolutionising manufacturing. As companies strive to accelerate drug development, our solution offers not just efficiency and cost-effectiveness but a transformative journey toward unparalleled success in the life sciences industry.

Tags :

Our latest blog articles

AI beyond the hype: what the Microsoft AI Tour Brussels taught us about moving beyond proof of concept to full-scale deployment

AI will represent 10% of global IT spending by 2028: here's where to invest

Cyber Resilience Act (CRA): how to comply (and what if you don’t)